Orbimed Advisors - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 124 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$3,889,000
-31.5%
2,124,9750.0%0.07%
-23.9%
Q1 2022$5,674,000
-59.2%
2,124,975
-33.9%
0.09%
-48.6%
Q4 2021$13,919,000
+50.1%
3,214,509
+76.4%
0.18%
+75.5%
Q3 2021$9,273,000
-3.2%
1,821,868
+20.4%
0.10%
+5.2%
Q2 2021$9,578,0001,513,1680.10%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,450,000$8,320,5001.17%
BVF INC/IL 6,595,801$8,508,5830.23%
Bronte Capital Management Pty Ltd. 925,245$1,193,5660.12%
Formidable Asset Management, LLC 318,111$410,3630.09%
Congress Park Capital LLC 112,450$145,0610.08%
Forefront Analytics, LLC 49,421$63,7540.04%
Ground Swell Capital, LLC 10,966$14,1460.02%
Clearline Capital LP 196,583$253,5920.02%
CORNERCAP INVESTMENT COUNSEL INC 81,352$104,9440.02%
ACADIAN ASSET MANAGEMENT LLC 2,646,190$3,4120.01%
View complete list of CYTOMX THERAPEUTICS INC shareholders